Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 3 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 3

From: The accuracy of whole-body 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the detection of ovarian cancer relapse in patients with rising cancer antigen 125 (CA-125) levels

Fig. 3

A 55-year-old female patient, with a history of ovarian cancer who underwent TAH and BSO. Her annual follow-up laboratory results showed elevated CA-125 up to 3200. Non-contrast-enhanced CT (A), PET (B) and PET/CT (C) images showed unremarkable CT findings, yet a metabolically active lesion was noted in the PET and PET/CT images at the operative bed (SUV max: 18) (white arrow). CT (D), PET (E) and PET/CT (F) images at a higher level showed another tiny peritoneal nodule (underneath the anterior abdominal wall) that could not be detected on CT while being obvious on PET and PET/CTimages (black arrow)

Back to article page